CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
Provided By PR Newswire
Last update: Oct 30, 2025
PRINCETON, N.J., Oct. 30, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report third quarter 2025 financial results and recent business highlights after the market close on Thursday, November 13, 2025.
Read more at prnewswire.com
